ArticleFrontiers in cellular and infection microbiology2026
Predicting the global risk of chikungunya virus under climate change using ensemble species distribution models.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Climate change is expanding vector-borne disease ranges, yet Chikungunya virus (CHIKV) risk projections remain limited by single-model uncertainty and lack of vector integration. CHIKV, transmitted by Methods: Using hierarchical ensemble modeling in Biomod2, we first projected vector distributions based on 19 bioclimatic variables and elevation, then integrated vector suitability as biological predictors for CHIKV under 16 CMIP6 scenarios (4 SSPs × 4 GCMs, 2021-2100). Eleven algorithms were evaluated and ensembled to minimize uncertainty. Results: Ensemble models achieved excellent performance ( Discussion: Multi-model projections identify region-specific invasion risks, with previously unaffected temperate areas emerging as high-priority surveillance zones by 2100. These findings provide actionable risk maps for targeted vector control and preparedness strategies in 139 at-risk countries, particularly those lacking population immunity. Model heterogeneity underscores the necessity of ensemble approaches for climate-health policy planning.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.